Funding Rounds
Leyden Labs Series B (2022, $140M)
Leyden LabsManufacturer of medicines to protect from the threat of respiratory viruses
Summary
Stage: Series B
Raised Amount: $140.00M
Raised Date: 2022-01-01
Stage: Series B
Raised Amount: $140.00M
Raised Date: 2022-01-01
